PDA Italy Chapter

Two days fully dedicated to the latest developments in relation to visual inspection with a deep focus on the impact of:

• New regulations,
• Automated systems,
• Best practices learnt by real cases.

At this event, we will present and discuss new developments and expectations in the field of Visual Inspection, which continues to be critical to manufacturing and delivering high-quality injectable medicines.
Starting from the regulatory scenario, which continues to evolve rapidly with new or revised guidance, we will investigate VI’s new requirements and implementation within pharmaceutical manufacturing.

Special attention will be given to difficult-to-inspect parenteral (DIP) products, such as lyophilized products, and to the role of Container Closure Integrity Testing.
Technological advancements, like the use of AI in image analysis and predictive maintenance, will also be discussed.

The agenda will include a guided tour at the Antares Vision Group plant dedicated to inspection machines with the opportunity to visit the test laboratory and the production area.